BRIEF-Carisma Therapeutics - CEO Steven Kelly To Leave Effective Nov 15 - SEC Filing

Reuters10-16

BRIEF-Carisma <a href="https://laohu8.com/S/LENZ">Therapeutics</a> - CEO Steven Kelly To Leave Effective Nov 15 - SEC Filing

Oct 15 (Reuters) - Carisma Therapeutics Inc CARM.PK:

AS PART OF WIND DOWN ACTIVITIES, CEO STEVEN KELLY TO LEAVE EFFECTIVE NOV 15 - SEC FILING
TO APPOINT CONSULTANT TO SERVE AS CEO & MANAGE REMAINING WIND-DOWN ACTIVITIES

Source text: [ID:n0001104659-25-099740]

Further company coverage: CARM.PK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2575499752?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-16 05:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575499752","market":"us","top_or_hot":-1,"title":"BRIEF-Carisma Therapeutics - CEO Steven Kelly To Leave Effective Nov 15 - SEC Filing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Carisma <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> - CEO Steven Kelly To Leave Effective Nov 15 - SEC Filing</title></head><body><p><span>Oct 15 (Reuters)</span><span> - </span>Carisma Therapeutics Inc <span>CARM.PK</span>:</p><ul><li><p>AS PART OF WIND DOWN ACTIVITIES, CEO STEVEN KELLY TO LEAVE EFFECTIVE NOV 15 - SEC FILING</p></li><li><p>TO APPOINT CONSULTANT TO SERVE AS CEO &amp; MANAGE REMAINING WIND-DOWN ACTIVITIES</p></li></ul><p>Source text: [ID:n0001104659-25-099740]</p><p>Further company coverage: <span>CARM.PK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Carisma Therapeutics - CEO Steven Kelly To Leave Effective Nov 15 - SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Carisma Therapeutics - CEO Steven Kelly To Leave Effective Nov 15 - SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-16 05:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Carisma <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> - CEO Steven Kelly To Leave Effective Nov 15 - SEC Filing</title></head><body><p><span>Oct 15 (Reuters)</span><span> - </span>Carisma Therapeutics Inc <span>CARM.PK</span>:</p><ul><li><p>AS PART OF WIND DOWN ACTIVITIES, CEO STEVEN KELLY TO LEAVE EFFECTIVE NOV 15 - SEC FILING</p></li><li><p>TO APPOINT CONSULTANT TO SERVE AS CEO &amp; MANAGE REMAINING WIND-DOWN ACTIVITIES</p></li></ul><p>Source text: [ID:n0001104659-25-099740]</p><p>Further company coverage: <span>CARM.PK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CARM","symbol_name":"Carisma Therapeutics, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nFWN3VW1X9:1","article_id":"2575499752","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575499752","pubTimestamp":1760565137,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Carisma Therapeutics - CEO Steven Kelly To Leave Effective Nov 15 - SEC FilingOct 15  - Carisma Therapeutics Inc CARM.PK:AS PART OF WIND DOWN ACTIVITIES, CEO STEVEN KELLY TO LEAVE EFFECTIVE NOV 15 - SEC FILINGTO APPOINT CONSULTANT TO SERVE AS CEO & MANAGE REMAINING WIND-DOWN ACTIVITIESSource text: [ID:n0001104659-25-099740]Further company coverage: CARM.PK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CARM":"Carisma Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"简介-Carisma Therapeutics-首席执行官Steven Kelly将于11月15日离职-SEC备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CARM":0.9},"content_text":"BRIEF-Carisma Therapeutics - CEO Steven Kelly To Leave Effective Nov 15 - SEC FilingOct 15 (Reuters) - Carisma Therapeutics Inc CARM.PK:AS PART OF WIND DOWN ACTIVITIES, CEO STEVEN KELLY TO LEAVE EFFECTIVE NOV 15 - SEC FILINGTO APPOINT CONSULTANT TO SERVE AS CEO & MANAGE REMAINING WIND-DOWN ACTIVITIESSource text: [ID:n0001104659-25-099740]Further company coverage: CARM.PK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2575499752","isCrawlerRequest":true}